Tim Dohrmann

WRAP 🗞️ Landmark aged care deal for @IntelicareLtd; Petra Capital sees ~335% upside in @KalamazooRes; @NWRcomms Melbourne Resources Lunch on next week 📷 Read more: tinyurl.com/ycyw6xe4 📩Subscribe to the Weekly Wrap: lnkd.in/gkS4QgnF

WRAP 🗞️ More gold for @ManyPeaksASX at Ferké; Advanced Innergy acquires Norway aquaculture business; Curran & Co initiates on @nh3cleanenergy with 380% upside 📷 Read more: lnkd.in/giVaMgXX 📩Subscribe to the Weekly Wrap: lnkd.in/gkS4QgnF

Organic #cannabis co $ECS Botanics returns to profit in H1 with 2 straight cash flow positive qtrs. - Sales up 16.5% to $11.3m - EBITDA of $0.8m, margins expand - Branded D2C now ~60% of revenue Investor webinar at 11am AEDT on Wed 4 Mar: register here: us02web.zoom.us/webinar/regist…

WRAP 🗞️ @DickerData FY25 gross revenue nears $4 billion; @wagnersholding increases FY26 guidance with outperformance in 1H; Appen achieves 250% EBITDA jump 📷 Read more: lnkd.in/gwz3-ddp 📩Subscribe to the Weekly Wrap: lnkd.in/gkS4QgnF

🎥 $ECS ECS Botanics MD joins TMB to discuss their recent partnership with German Distributor Nimbus Health as it enters Europe’s largest cannabis market. ✅ First sales are targeted for April 2026, with the OzSun brand launch imminent. 🗓️ @BotanicsEcs

WRAP 🗞️ @codanlimited revenue up 29% to $394M in 1H 26; @UniversalStore sales jump 14% in 1H; @Lycopodium delivers $174.5M HY revenue; 40% increase for @SHAPE_Australia's HY dividend 📷Read more: lnkd.in/g3JmX4PN 📩Subscribe to the Weekly Wrap: lnkd.in/gkS4QgnF

$ECS @GBA_Capital has released a Company Snapshot on organic medicinal #cannabis biz ECS Botanics (ASX: ECS), highlighting ECS's improving cashflow profile, operational progress and the foundations to support the next phase of growth. Read full note here: mcusercontent.com/08c9b9108c069c…

📈 $ECS ECS Botanics has partnered with German distributor Nimbus Health, giving access to national pharmacy reach as it enters Europe’s largest cannabis market (~€500m) 🤝 First sales targeted for April 2026, with OzSun launch imminent @BotanicsEcs 🔗 cdn-api.markitdigital.com/apiman-gateway…

WRAP 🗞️ Appen surges +30% on strong Q4 revenue; @TungstenMinTGN jumps following $53m raise; @SHNMetals20 hits high-grade gold and silver at Liontown; 📷 Read more: lnkd.in/gm8fdwMs 📩Subscribe to the Weekly Wrap: lnkd.in/gkS4QgnF

Lava Blue, HaloCell partner to develop Australian perovskite solar supply chain dlvr.it/TQQlcv #solar

WRAP 🗞️ @vitrafy soars on IMV strategic partnership; @WAFresources gains on production update; @LarvottoR surges on antimony listing 📷 Read more: lnkd.in/gGsaud-k 📩Subscribe to the Weekly Wrap: lnkd.in/gkS4QgnF

A strong trading day for $ECS, +17% w/ 10m shares traded on a healthy qtrly report: - $218k positive cash flow (vs -$1.3m PCP) - B2C is now 65% of revenue - multiple product launches - $5m cash + facilities 📝 wcsecure.weblink.com.au/pdf/ECS/030458… #MedicinalCannabis #PotStocks @BotanicsEcs

Following recent comments from Trump on easing US #cannabis restrictions, ECS Botanics (#ASX: $ECS) has launched a strategic review targeting one of the world’s biggest #medicinalcannabis mkts. @BotanicsEcs is GMP-certified, cashed up & export-ready. 🔗: wcsecure.weblink.com.au/pdf/ECS/030378…

WRAP 🗞️ @symal_au steps up Qld expansion; @EquusEnergy prepares for ASX listing next week; @canaccord initiates on Aurum Resources with $1.50 PT 📷 Read more: lnkd.in/gjYxyugb 📩Subscribe to the Weekly Wrap: lnkd.in/gkS4QgnF

$ECS ECS Botanics prepares 2026 launch of AVANI AVA women’s-health cannabis range tinyurl.com/25elg443 #ECS #ASX #ASXNews

ECS Botanics @ECSBotanics launches AVANI AVA Women's Health cannabis range in January 2026, targeting over 40% of medicinal cannabis approvals. $ECS stockwirex.com/asx-stock-news…

📽️ $PKY Pathkey.AI Executive Chairman Damon Rasheed joins TMB to discuss their flagship TrialKey platform, how they differentiate from competitors, detail the recent capital raise + update on their partnership with L39 Capital. @OpylAI

🤝 $PKY Pathkey.AI has successfully completed a $2.5M placement, aimed at accelerating the rollout of its AI-driven TrialKey platform and supporting targeted acquisitions within the broader AI sector. 💰 @OpylAI themarketbull.com.au/2025/11/27/pat…

EdenX Raises US$5M to Expand Platform in Australia and Singapore fintechnews.sg/122416/funding… #fintech #singapore

WRAP 🗞️ ReNerve surges on US healthcare wins; @SHAPE_Australia diversifies with Arden Group acquisition; Bell Potter initiates on @FrontierASX with $0.50/sh PT 📷 Read more: lnkd.in/gENcAnTN 📩Subscribe to the Weekly Wrap: lnkd.in/gkS4QgnF